 | | | | A mediator reported on Tuesday that members of the Sackler family that own Purdue Pharma and U.S. states opposed to the OxyContin-maker's bankruptcy exit plan are "even closer" to a settlement on claims that the company fueled a U.S. opioid epidemic. | | | | | | The U.S. Centers for Disease Control and Prevention stands by its mask-wearing guidance for public K-12 schools with COVID-19 cases still high nationwide, even as some states plan to relax masking rules, CDC Director Dr. Rochelle Walensky told Reuters on Tuesday. | | | | | | Uganda is preparing legislation to make COVID-19 jabs mandatory in a country with low levels of vaccination, a senior health official said. | | | | | | The European Union's drug regulator launched a review to evaluate whether the Pfizer/BioNTech , COVID-19 vaccine can be used as a third booster shot in adolescents aged 12 to 15, even after several countries in the region have already started such a campaign. | | | | | | Turkey has recorded 111,096 new COVID-19 infections in the space of 24 hours, just below the record daily high from the previous week, as well as its highest daily death toll in months, health ministry data showed on Tuesday. | | | | | | Italy reported 101,864 COVID-19 related cases on Tuesday, against 41,247 the day before, the health ministry said, while the number of deaths rose to 415 from 326. | | | | | | Britain reported 314 new COVID-19 deaths and a further 66,183 cases, official data showed on Tuesday. | | | | | | Johnson & Johnson quietly shut down the only plant making usable batches of its COVID-19 vaccine late last year, the New York Times reported, citing people familiar with the decision. | | | | | | Amgen Inc said on Tuesday it would buy back up to $6 billion of its shares in the first quarter and forecast profit to more than double by 2030 on strong sales of its oncology drugs, biosimilars and other important products. | | | | | | Pfizer Inc said on Tuesday it expects 2022 sales of its COVID-19 vaccine and antiviral pill to top $54 billion, but that fell short of lofty Wall Street estimates and its shares were off about 3%. | | | | | |
